EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An engineered cellular carrier delivers miR-138–5p to enhance mitophagy and protect hypoxic-injured neurons via the DNMT3A/Rhebl1 axis

Xingjia Zhu, Qianqian Liu, Fengwei Zhu, Rui Jiang, Zhichao Lu, Chenxing Wang, Peipei Gong, Qi Yao, Tian Xia, Jie Sun, Fei Ju, Defeng Wang und 4 weitere

Acta Biomaterialia · 2024-09 · 186 · 424-438

DOI: 10.1016/j.actbio.2024.07.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-09. Verfasst von Xingjia Zhu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Research Center of Clinical Medicine, Neuro-Microscopy and Minimally Invasive Translational Medicine Innovation Center, A…. Hauptthemen laut MEDLINE: Mitophagy, DNA Methyltransferase 3A, MicroRNAs, Neurons. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nantong University, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitophagy influences the progression and prognosis of ischemic stroke (IS). However, whether DNA methylation in the brain is associated with altered mitophagy in hypoxia-injured neurons remains unclear. Here, miR-138-5p was found to be highly expressed in exosomes secreted by astrocytes stimulated with oxygen and glucose deprivation/re-oxygenation (OGD/R), which could influence the recovery of OGD/R-injured neurons through autophagy. Mechanistically, miR-138-5p promotes the stable expression of Ras homolog enriched in brain like 1(Rhebl1) through DNA-methyltransferase-3a (DNMT3A), thereby enhancing ubiquitin-dependent mitophagy to maintain mitochondrial homeostasis. Furthermore, we employed glycosylation engineering and bioorthogonal click reactions to load mirna onto the surface of microglia and deliver them to injured region utilising the inflammatory chemotactic properties of microglia to achieve drug-targeted delivery to the central nervous system (CNS). Our findings demonstrate miR-138-5p improves mitochondrial function in neurons through the miR-138-5p/DNMT3A/Rhebl1 axis. Additionally, our engineered cell vector-targeted delivery system could be promising for treating IS. STATEMENT OF SIGNIFICANCE: In this study, we demonstrated that miR-138-5p in exosomes secreted by astrocytes under hypoxia plays a critical role in the treatment of hypoxia-injured neurons. And we find a new target of miR-138-5p, DNMT3A, which affects neuronal mitophagy and thus exerts a protective effect by regulating the methylation of Rbebl1. Furthermore, we have developed a carrier delivery system by combining miR-138-5p with the cell membrane of microglia and utilized the inflammatory chemotactic properties of microglia to deliver this system to the brain via intravenous injection. This groundbreaking study not only provides a novel therapeutic approach for ischemia-reperfusion treatment but also establishes a solid theoretical foundation for further research on targeted drug delivery for central nervous system diseases with promising clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyDNA Methyltransferase 3AMicroRNAsNeuronsAnimalsCell HypoxiaHumansDNA (Cytosine-5-)-MethyltransferasesExosomesMiceAstrocytes

Stichwörter der Autor:innen

AstrocyteMCAOMitophagyOGD/RmiR-138–5pneuron

Substanzen

DNA Methyltransferase 3AMicroRNAsDNMT3A protein, humanDNA (Cytosine-5-)-MethyltransferasesDnmt3a protein, mouseMIRN138 microRNA, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Research Center of Clinical Medicine, Neuro-Microscopy and Minimally Invasive Translational Medicine Innovation Center, Affiliated Hospital of Nantong University, Medical School of Nantong Un…
  • Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, 226001, Nantong, PR China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong University, 226001, Nantong, PR China.
  • Department of Pathogen Biology, School of Medicine, Nantong University, 226001, Nantong, PR China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong University, 226001, Nantong, PR China. Electronic address: zhouyoulang@ntu.edu.cn.
  • Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, 226001, Nantong, PR China. Electronic address: youbo@ntu.edu.cn.

Förderung

  • Nantong University
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National Institutes of Health

Zitieren

APA

Zhu, X., Liu, Q., Zhu, F., Jiang, R., Lu, Z., Wang, C., Gong, P., Yao, Q., Xia, T., Sun, J., Ju, F., Wang, D., Sun, R., Zhou, Y., You, B., & Shi, W. (2024). An engineered cellular carrier delivers miR-138–5p to enhance mitophagy and protect hypoxic-injured neurons via the DNMT3A/Rhebl1 axis. Acta Biomaterialia, 186, 424-438. https://doi.org/10.1016/j.actbio.2024.07.059

Vancouver

Zhu X, Liu Q, Zhu F, Jiang R, Lu Z, Wang C, et al. An engineered cellular carrier delivers miR-138–5p to enhance mitophagy and protect hypoxic-injured neurons via the DNMT3A/Rhebl1 axis. Acta Biomaterialia. 2024;186:424-438. doi:10.1016/j.actbio.2024.07.059

BibTeX
@article{Zhu2024,
  author = {Zhu, Xingjia and Liu, Qianqian and Zhu, Fengwei and Jiang, Rui and Lu, Zhichao and Wang, Chenxing and Gong, Peipei and Yao, Qi and Xia, Tian and Sun, Jie and Ju, Fei and Wang, Defeng and Sun, Ruifan and Zhou, Youlang and You, Bo and Shi, Wei},
  title = {An engineered cellular carrier delivers miR-138–5p to enhance mitophagy and protect hypoxic-injured neurons via the DNMT3A/Rhebl1 axis},
  journal = {Acta Biomaterialia},
  year = {2024},
  volume = {186},
  pages = {424--438},
  doi = {10.1016/j.actbio.2024.07.059}
}
Kostenlos starten →